Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers Panel Discussion

Discussion led by Chairs (ID 187)

Lecture Time
08:20 - 09:00
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00